Appointment of Joint Corporate Broker

RNS Number : 9074P

Alliance Pharma PLC

06 September 2017

 

For immediate release

6 September 2017

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Appointment of Joint Corporate Broker

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce the appointment of Investec Bank plc as joint corporate broker to act alongside Numis Securities Limited, the Company's Nominated Adviser and joint corporate broker.

For further information:

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive Officer Peter Butterfield, Deputy Chief Executive Officer Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan	+ 44 (0) 20 7466 5000
Mark Court / Sophie Cowles
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black / Toby Adcock
Investec Bank plc	[phone]
Corporate Finance: Daniel Adams / Ed Thomas Corporate Broking: Patrick Robb / Rob Baker

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 

END

 

 

APPBIGDCBUGBGRU